Sorafenib for Desmoid Tumors. A Cost Analysis: Too Much for Too Little?
Publication/Presentation Date
10-2020
Volume
231
Issue
4
First Page
213
Last Page
213
Published In/Presented At
Johns, Michael S. DO; Merritt, William T. MD; Rhodes, Lori MD; Ford, Candice DO; Thompson, Mark PhD; Lee, William M. MD; James Petrelli, Nicholas MD, FACS; James Tiesi, Gregory MD, FACS. Sorafenib for Desmoid Tumors. A Cost Analysis: Too Much for Too Little?. Journal of the American College of Surgeons 231(4):p e213, October 2020. | DOI: 10.1016/j.jamcollsurg.2020.08.569
Disciplines
Medicine and Health Sciences
Department(s)
Department of Surgery
Document Type
Article
COinS
